From: The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy
Groups | T value/χ2 | P | ||
---|---|---|---|---|
NC | DM | |||
Gender (M/F) | 31/49 | 35/45 | 0.413 | 0.630☆ |
Age (years) | 53.1 ± 7.0 | 54.1 ± 7.4 | − 0.845 | 0.4 |
BMI (kg/m2) | 23.8 ± 1.3 | 24.7 ± 2.0 | − 3.465 | 0.001* |
SBP (mmHg) | 127.1 ± 9.1 | 132.3 ± 12.1 | − 3.097 | 0.002* |
DBP (mmHg) | 77.2 ± 6.2 | 77.4 ± 5.4 | − 0.284 | 0.777 |
HBA1c (%) | 5.2 ± 0.4 | 10.6 ± 1.5 | − 30.098 | 0.000* |
FPG (mmol/l) | 4.6 ± 0.6 | 12.4 ± 1.8 | − 38.143 | 0.000* |
2hPG (mmol/l) | 5.7 ± 0.4 | 16.5 ± 1.2 | − 76.735 | 0.000* |
HOMA-IR | 1.4 ± 0.3 | 3.3 ± 0.5 | − 26.932 | 0.000* |
IL-6 (pg/l) | 94.7 ± 11.2 | 167.90 ± 15.46 | − 34.292 | 0.000* |
TC (mmol/l) | 4.0 ± 0.7 | 5.0 ± 1.0 | − 7.198 | 0.0008* |
TG (mmol/l) | 1.5 ± 0.2 | 2.8 ± 0.9 | − 13.499 | 0.000* |
LDL (mmol/l) | 2.5 ± 0.3 | 3.3 ± 0.8 | − 8.112 | 0.000* |
HDL (mmol/l) | 1.4 ± 0.3 | 1.1 ± 0.4 | 6.121 | 0.000* |
3-NT (nmol/l) | 78.6 ± 7.4 | 121.5 ± 9.9 | − 31.13 | 0.000* |
SOD (U/ml) | 124.8 ± 17.6 | 102.6 ± 20.5 | 7.332 | 0.000* |
8-OHdG (ng/ml) | 6.9 ± 3.8 | 25.4 ± 4.4 | − 28.471 | 0.000* |
GSH (mg/l) | 152.5 ± 18.9 | 134.3 ± 15.3 | 6.663 | 0.000* |
CRP (mg/l) | 2.6 ± 0.7 | 8.46 ± 1.79 | − 27.477 | 0.000* |